View the LUCILENACAP registration information details.
Back to drug list
ItemsDrug Registration information
ID1742
No1742
Brand NameLUCILENACAP
IngredientsLENACAPAVIR 300 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 5'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF HIV-1 INFECTION IN HEAVILY TREATMENT -EXPERIENCED ADULTS WITH MULTIDRUG RESISTANT HIV-1 INFECTION FAILING THEIR CURRENT ANTIRETROVIRAL REGIMEN DUE TORESISTANCE, INTOLERANCE, OR SAFETY CONSIDERATION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionORANGE, ROUND TABLET, WITH LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 1316/25
FDD Registration Date07/04/2025
Expiry Date06/04/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA